First Batch of China’s Grant Medicines to arrive in Sri Lanka on June 03
The first Batch of China’s Grant Medicines worth 500 million RMB was scheduled to arrive on 3rd June, the Chinese Embassy in Sri Lanka said.
“With joint efforts of all relevant authorities from both China and Sri Lanka, 512,640 syringes of life-saving Enoxaparin Sodium Injection worth of 10 million RMB, the first batch of Chinese government’s 500 million RMB grant to Sri Lankan people have been arranged and will be delivered to Sri Lanka via two consignments,” the Embassy said in a statement.
“One consignment of 256,320 syringes is scheduled to arrive at Colombo in the mid-night of June 3rd by flight CX3119, with the total volume of 40 cubic meters and weight of 4.3 metric tons,” it said.
“The other one is expected to arrive in the second half of the month. Enoxaparin sodium is an anticoagulant medication (blood thinner), commonly used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks, or during hemodialysis. The two consignments of 512,640 syringes donated by China will be sufficient for Sri Lanka’s use for 6 months.
China relates deeply to the difficulties and challenges faced by Sri Lankan people.
The Chinese Embassy in Sri Lanka will continue to work closely with both Beijing and Colombo to follow through the important agreement reached by the leaders of our two countries and provide much-needed livelihood assistance for Sri Lankan people as top priority.
Latest Headlines in Sri Lanka
- Excavation begins near Veyangoda to uncover reported treasure November 22, 2024
- Thai vets plan to trim tusks of Muthu Raja, elephant repatriated from Sri Lanka November 22, 2024
- Sri Lanka to provide fuel-efficient vehicles for MPs to cut tax waste November 22, 2024
- 29 deputy ministers sworn in under Sri Lanka’s new government November 21, 2024
- Sri Lankan President unveils vision in 10th Parliament policy statement November 21, 2024